What Biological Mechanisms Of Melanogenesis Should Practitioners Consider When Using Aesthetic Laser Systems To Treat Hyperpigmentation? Master Safe Targeting To Avoid Pih

Practitioners should treat melanogenesis as an active biological process, not merely as excess pigment to be removed. Inflammation, ultraviolet exposure, and hormonal signaling can stimulate melanocytes to produce melanin through tyrosinase-mediated oxidation. The resulting melanin is packaged into melanosomes and transferred through melanocyte dendrites to surrounding keratinocytes, where it becomes clinically visible as hyperpigmentation. Laser parameters must therefore target pigment precisely while avoiding epidermal injury that could reactivate melanogenesis and cause post-inflammatory hyperpigmentation (PIH).

The central principle is controlled pigment targeting with minimal collateral inflammation. Successful treatment depends on understanding pigment depth, melanocyte activity, melanosome distribution, and the patient’s phototype before selecting wavelength, pulse duration, fluence, and cooling strategy.

How Melanogenesis Produces Hyperpigmentation

Melanocytes are the source of new pigment

Melanin is synthesized inside epidermal melanocytes, primarily within specialized organelles called melanosomes. Melanocytes then transport these melanosomes through dendrites to neighboring keratinocytes.

This means that visible pigmentation may reflect both increased melanin production and increased distribution of pigment throughout the epidermis.

Tyrosinase controls a critical synthesis step

Melanogenesis involves the tyrosinase-mediated oxidation of melanin precursors. Increased tyrosinase activity can raise the rate of melanin production following ultraviolet exposure, inflammation, or hormonal stimulation.

This pathway explains why pigment can recur after treatment if the underlying stimulus remains active or if the procedure itself creates significant inflammation.

UV and hormonal signals activate melanocytes

Ultraviolet radiation activates signaling pathways involving melanocortin receptors and other cellular mediators. These signals increase melanocyte activity and can produce diffuse hyperpigmentation or localized lesions such as lentigines.

Hormonal changes can produce a similar increase in melanogenic signaling, particularly in conditions such as melasma.

Melanin type affects optical behavior

Melanosomes may contain eumelanin, which is associated with brown to black pigmentation, or pheomelanin, which is lighter and structurally different. Eumelanosomes are generally more mature and express substantially more tyrosinase than pheomelanosomes.

These differences influence how pigment absorbs laser energy and how consistently a lesion responds to treatment.

Why Pigment Depth Matters Before Laser Treatment

Epidermal pigment is more accessible

Pigment concentrated in the epidermis is closer to the surface and is generally more accessible to appropriately selected light or laser energy. Superficial pigment may respond to modalities designed for selective absorption by melanin without requiring substantial dermal heating.

However, superficial location does not eliminate risk. Excessive epidermal heating can damage the surrounding tissue and provoke inflammation.

Dermal pigment requires greater restraint

When melanin or melanophages are located deeper in the dermis, energy must travel farther to reach the target. Increasing energy indiscriminately can expose the epidermis and basement membrane zone to unnecessary thermal stress.

Melasma, for example, may have epidermal, dermal, or mixed components. A clinical assessment of pigment depth is therefore essential before choosing a wavelength, pulse width, or fractional technique.

Diagnosis should guide treatment intensity

A practitioner should evaluate basal-layer pigment density, ultraviolet damage, pigment distribution, and the patient’s Fitzpatrick phototype. Darker or reactive skin types require particular attention because melanocytes can respond strongly to procedural inflammation.

The goal is not the highest possible fluence. It is the minimum effective fluence that produces an appropriate clinical endpoint without excessive tissue injury.

How Laser Energy Interacts With Melanin

Selective photothermolysis provides the treatment framework

Aesthetic lasers emit specific wavelengths that are preferentially absorbed by target chromophores such as melanin. The absorbed light is converted into heat, allowing controlled damage to pigment-containing structures while preserving surrounding tissue.

This principle is known as selective photothermolysis. Its safety depends on matching wavelength, pulse duration, spot size, fluence, and cooling to the target and the patient’s skin characteristics.

Pulse duration determines how heat is confined

Picosecond and Q-switched systems use very short pulses to deliver energy to pigment particles over a limited time period. The intended effect may include photothermal and photoacoustic disruption of pigment, depending on the device and settings.

Short pulses can help limit heat diffusion, but they do not make treatment risk-free. Excessive energy or repeated passes can still produce inflammation, epidermal injury, or unwanted pigment alteration.

Wavelength selection must match the target

Different wavelengths penetrate to different depths and are absorbed differently by melanin. A superficial pigment cluster and a deeper dermal target should not automatically be treated with the same settings.

Nd:YAG, Alexandrite, picosecond, Q-switched, and fractional systems may have different roles, but device selection should follow the pigment’s depth and morphology rather than the device label alone.

Cooling protects the epidermis

Integrated intra-operative cooling helps dissipate surface heat and reduce epidermal injury. This is especially important when the target lies deeper than the epidermis or when treating darker phototypes.

Cooling supports the therapeutic window by helping preserve healthy surface tissue while energy is delivered to the intended pigment target.

The Biological Risks Practitioners Must Anticipate

Thermal injury can trigger PIH

Inflammation is one of the main drivers of post-inflammatory melanogenesis. If laser treatment causes excessive epidermal trauma, cytokine release and tissue injury can stimulate melanocytes after the procedure.

The treatment can therefore worsen the very condition it was intended to improve. This risk is particularly important in reactive skin and Fitzpatrick III–V phototypes.

Hypopigmentation can result from excessive targeting

Over-treatment may suppress or destroy melanocyte function in the treated area, producing hypopigmentation. The risk increases when fluence is too high, passes overlap excessively, or treatments are repeated before the skin has recovered.

A gradual response is generally more controllable than attempting to remove all visible pigment in one aggressive session.

The basement membrane zone requires protection

In mixed or dermal pigmentation, practitioners may be tempted to use more energy to reach deeper pigment. Excessive thermal exposure can disrupt the basement membrane zone and increase the likelihood of prolonged inflammation, uneven pigment, or scarring.

The treatment objective is controlled pigment clearance, not maximal tissue disruption.

Understanding the Trade-offs

More energy does not guarantee better clearance

Higher fluence may create a stronger immediate response, but it also increases thermal damage and inflammatory signaling. Immediate whitening, darkening, erythema, or textural change must be interpreted as clinical endpoints rather than proof that additional energy is needed.

Settings should be adjusted according to the observed response, device specifications, skin type, and treatment area.

Fractional ablation has a broader biological effect

Fractional lasers can ablate microscopic columns of epidermis or create controlled dermal thermal injury. These mechanisms may promote epithelial renewal and collagen remodeling while also helping address texture and some pigmented lesions.

Because fractional treatment intentionally creates tissue injury, it carries a different inflammatory burden from pigment-selective treatment. It should be selected for an appropriate indication and used cautiously when PIH risk is high.

Corrective treatment is not a substitute for prevention

Fractional CO2 treatment may support dermal remodeling and texture restoration after certain thermal injuries or scarring problems. It does not remove the need for careful initial parameter selection and may itself create additional inflammation if used indiscriminately.

Persistent pigment change, scarring, or unexpected hypopigmentation requires clinical reassessment rather than automatic escalation.

Targeting More Than Melanin Synthesis

Inhibiting tyrosinase addresses production

Ingredients such as ascorbic acid, arbutin, glabridin, and hesperidin can act on pathways associated with tyrosinase activity. These approaches aim to reduce the formation of new melanin and may complement energy-based treatment.

They do not replace appropriate laser selection, because they act through biochemical modulation rather than selective photothermolysis.

Melanosome transfer is a separate target

Niacinamide does not primarily inhibit tyrosinase. Its relevant action is reducing the transfer of melanosomes from melanocytes to keratinocytes, with reported reductions of approximately 35% to 68% in the supplied reference.

This distinction matters because lowering pigment production and reducing pigment distribution are biologically different strategies.

Depigmentation can also involve pigment dispersion

Liquiritin is described as supporting depigmentation through melanin dispersion and removal of epidermal stain without directly inhibiting tyrosinase. This provides another example of why hyperpigmentation protocols should not be evaluated only through the lens of melanin synthesis.

A multimodal plan may address production, transfer, persistence, and procedural inflammation at the same time.

Making the Right Choice for Your Goal

A sound protocol begins with diagnosis and proceeds through conservative, observable, and repeatable treatment decisions.

If your primary focus is superficial epidermal pigment: Select a wavelength and pulse strategy that targets melanin while preserving the epidermis, and use cooling to limit surface heat.
If your primary focus is dermal or mixed pigment: Confirm pigment depth before increasing energy, because deeper targeting can raise the risk of epidermal injury and PIH.
If your primary focus is treating darker or reactive skin: Use the minimum effective fluence, monitor real-time clinical endpoints, and prioritize inflammation control over rapid clearance.
If your primary focus is preventing recurrence: Address ultraviolet, inflammatory, and hormonal drivers while considering adjunctive approaches that inhibit tyrosinase or melanosome transfer.
If your primary focus is correcting texture or established scarring: Consider fractional remodeling only when its broader injury-and-repair mechanism matches the clinical indication.

When practitioners understand how melanocytes produce, package, transfer, and reactivate melanin, laser treatment becomes a controlled biological intervention rather than a simple attempt to erase visible pigment.

Summary Table:

Mechanism	Clinical Implication	Laser Consideration
Melanocyte activation	Increased melanin production	Avoid excessive epidermal heating to prevent PIH
Tyrosinase activity	Rate of melanin synthesis	Use lower fluence in reactive skin types
Melanosome transfer	Pigment distribution to keratinocytes	Combine with topical agents like niacinamide
Eumelanin vs. pheomelanin	Absorption differences	Select wavelength based on melanin type
Epidermal vs. dermal pigment	Target depth	Choose appropriate wavelength and pulse duration

At BELIS, we provide professional-grade aesthetic laser systems designed for clinics and premium salons. Our portfolio includes Diode, Alexandrite, CO2 Fractional, Erbium, Nd:YAG, Pico, IPL, and PDT devices—all engineered to help you treat hyperpigmentation safely and effectively. Contact our experts today to find the ideal system for your practice and enhance your treatment outcomes. Contact us now!